We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.15B Turnover 18.82%
1-Year Est. Return 43.46%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$266M
AUM Growth
-$43.4M
Cap. Flow
-$44.2M
Cap. Flow %
-16.65%
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22
Avg Time Held
1.2 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.06M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$2.27M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.93M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$1.56M
5
AXON icon
Axon Enterprise
AXON
+$1.1M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$13M
2
MGNX icon
MacroGenics
MGNX
+$6.84M
3
BABA icon
Alibaba
BABA
+$3.42M
4
SGMO icon
SANGAMO THERAPEUTICS INC
SGMO
+$3.21M
5
HCA icon
HCA Healthcare
HCA
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 23.9%
2 Communication Services 19.6%
3 Energy 16.27%
4 Industrials 12.61%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AEP icon
76
American Electric Power
AEP
$69.2B
$655K 0.25%
10,790
– –
2013 Q2
6 quarters
ORCL icon
77
Oracle
ORCL
$389B
$655K 0.25%
14,555
– –
2013 Q2
6 quarters
INTU icon
78
Intuit
INTU
$86.9B
$567K 0.21%
6,150
– –
2013 Q2
6 quarters
OXY icon
79
Occidental Petroleum
OXY
$62.4B
$536K 0.2%
6,661
-1,533
-19% -$127K
2013 Q2
6 quarters
TROW icon
80
T. Rowe Price
TROW
$21.5B
$509K 0.19%
5,930
– –
2013 Q2
6 quarters
GE icon
81
GE Aerospace
GE
$326B
$500K 0.19%
4,132
– –
2013 Q2
6 quarters
MRK icon
82
Merck
MRK
$360B
$483K 0.18%
8,908
– –
2013 Q2
6 quarters
PH icon
83
Parker-Hannifin
PH
$121B
$481K 0.18%
3,727
– –
2013 Q2
6 quarters
SPY icon
84
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$442K 0.17%
2,150
– –
2013 Q4
4 quarters
FISV icon
85
Fiserv Inc
FISV
$25.3B
$433K 0.16%
12,200
– –
2013 Q2
6 quarters
BMY icon
86
Bristol-Myers Squibb
BMY
$122B
$419K 0.16%
7,097
– –
2013 Q2
6 quarters
COR icon
87
Cencora
COR
$65.1B
$400K 0.15%
4,436
– –
2013 Q2
6 quarters
LLL
88
DELISTED
L3 Technologies, Inc.
LLL
$379K 0.14%
3,000
– –
2013 Q2
6 quarters
WMT icon
89
Walmart Inc
WMT
$943B
$374K 0.14%
13,065
– –
2013 Q2
6 quarters
LBRDA icon
90
DELISTED
Liberty Broadband Class A
LBRDA
$372K 0.14%
+7,421
New +$367K
2014 Q4
0 quarters
PG icon
91
Procter & Gamble
PG
$370B
$364K 0.14%
4,000
– –
2013 Q2
6 quarters
MDSO
92
DELISTED
Medidata Solutions, Inc.
MDSO
$320K 0.12%
6,700
– –
2013 Q3
5 quarters
ED icon
93
Consolidated Edison
ED
$41.5B
$287K 0.11%
4,350
– –
2013 Q2
6 quarters
GS icon
94
Goldman Sachs
GS
$257B
$276K 0.1%
1,425
– –
2013 Q2
6 quarters
XLV icon
95
State Street Health Care Select Sector SPDR ETF
XLV
$45.8B
$274K 0.1%
4,000
– –
2013 Q3
5 quarters
HES icon
96
DELISTED
Hess
HES
$266K 0.1%
3,600
– –
2013 Q2
6 quarters
BRK.B icon
97
Berkshire Hathaway Class B
BRK.B
$1.14T
$233K 0.09%
1,550
– –
2014 Q3
1 quarter
DD icon
98
DELISTED
Du Pont De Nemours E I
DD
$214K 0.08%
3,054
– –
2014 Q3
1 quarter
AST
99
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$187K 0.07%
+57,649
New +$232K
2014 Q4
0 quarters
BTX.WS icon
100
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$76K 0.03%
+72,341
New +$78.4K
2014 Q4
0 quarters
1 2 3
4
5

Similar funds

WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
HT
Heritage Trust Oklahoma City, Oklahoma $1.15B AUM 35.37% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.16B AUM 27.46% 1-Year Est. Return
CIG
Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Private Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.

  • Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
  • Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
  • Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
  • Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
  • Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
  • Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
  • Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.

Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.